17 Grants
2021
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX001407-05), 2016-10-01 -- 2021-09-30
2020
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX001407-04), 10/01/2016 -- 09/30/2020
2019
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL128827-04), $397,744USD, 04/01/2016 -- 03/31/2020
 
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX001407-03), 10/01/2016 -- 09/30/2020
2018
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL128827-03), $445,489USD, 04/01/2016 -- 03/31/2020
 
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX001407-02), 10/01/2016 -- 09/30/2020
 
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5UM1HL113457-07), $149,088USD, 03/15/2012 -- 02/28/2019
2017
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL128827-02), $457,720USD, 04/01/2016 -- 03/31/2020
 
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01CX001407-01A1), 10/01/2016 -- 09/30/2020
 
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5UM1HL113457-06), $527,074USD, 03/15/2012 -- 02/28/2019
2016
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL128827-01A1), $517,800USD, 04/01/2016 -- 03/31/2020
 
ShEEP Request for 3DBioFactory, regenHU Biosystem Architects
Murphy, Michael P
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1IS1BX003116-01A1), 05/01/2016 -- 09/30/2016
 
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
March, Keith L and Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4UM1HL113457-05), $514,474USD, 03/15/2012 -- 02/28/2019
2015
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
March, Keith L and Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5UM1HL113457-04), $206,758USD, 03/15/2012 -- 02/28/2019
2014
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
March, Keith L and Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5UM1HL113457-03), $531,086USD, 03/15/2012 -- 02/28/2019
2013
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
March, Keith L and Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5UM1HL113457-02), $515,656USD, 03/15/2012 -- 02/28/2019
2012
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
March, Keith L and Murphy, Michael P
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1UM1HL113457-01), $555,331USD, 03/15/2012 -- 02/28/2019